Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

161.

Dual antiplatelet therapy duration and mortality - Authors' reply.

Lancet.
Yeh RW, Elmariah S, Doros G, Kereiakes DJ, Mauri L.
| May 30, 2015
162.

African health leaders: claiming the future.

Lancet.
Binagwaho A, Crisp N.
| May 30, 2015
163.

Women and Health: the key for sustainable development.

Lancet.
Langer A, Meleis A, Knaul FM, Atun R, Aran M, Arreola-Ornelas H, Bhutta ZA, Binagwaho A, Bonita R, Caglia JM, Claeson M, Davies J, Donnay FA, Gausman JM, Glickman C, Kearns AD, Kendall T, Lozano R, Seboni N, Sen G, Sindhu S, Temin M, Frenk J.
| Sep 19, 2015
164.

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial.

Lancet.
Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion-Sileni V, Lebbe C, Mandalà M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Swann S, Legos JJ, Jin F, Mookerjee B, Flaherty K.
| Aug 01, 2015
165.

Global health security: the wider lessons from the west African Ebola virus disease epidemic.

Lancet.
Heymann DL, Chen L, Takemi K, Fidler DP, Tappero JW, Thomas MJ, Kenyon TA, Frieden TR, Yach D, Nishtar S, Kalache A, Olliaro PL, Horby P, Torreele E, Gostin LO, Ndomondo-Sigonda M, Carpenter D, Rushton S, Lillywhite L, Devkota B, Koser K, Yates R, Dhillon RS, Rannan-Eliya RP.
| May 09, 2015
166.

50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.

Lancet.
Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D.
| Jul 11, 2015
167.

An active shooter in our hospital.

Lancet.
Goralnick E, Walls R.
| May 02, 2015
168.

Risk factors for and origins of COPD.

Lancet.
Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB.
| May 02, 2015
169.

Reducing the burden of iatrogenic harm in children.

Lancet.
Carson-Stevens A, Edwards A, Panesar S, Parry G, Rees P, Sheikh A, Donaldson L.
| Apr 25, 2015
170.

The history and fate of the gold standard.

Lancet.
Jones DS, Podolsky SH.
| Apr 18, 2015
171.

Surgical palliative care in resource-limited settings.

Lancet.
Riesel JN, Mandigo M, Gillies R, Damuse R, Farmer PE, Cusack JC, Krakauer EL, Shulman LN.
| Aug 08, 2015
172.

Global surgery--going beyond the Lancet Commission.

Lancet.
Davies JI, Meara JG.
| Aug 08, 2015
173.

Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development.

Lancet.
Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SL, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Lundeg G, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W.
| Aug 08, 2015
174.

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.

Lancet.
Sax PE, Wohl D, Yin MT, Post F, DeJesus E, Saag M, Pozniak A, Thompson M, Podzamczer D, Molina JM, Oka S, Koenig E, Trottier B, Andrade-Villanueva J, Crofoot G, Custodio JM, Plummer A, Zhong L, Cao H, Martin H, Callebaut C, Cheng AK, Fordyce MW, McCallister S, Achenbach C.
| Jun 27, 2015
175.

On the (f)utility of pain.

Lancet.
Stonington SD.
| Apr 11, 2015
176.

Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial.

Lancet.
Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kobashigawa J, Baran D.
| Jun 27, 2015
177.

Diagnosis of reversible causes of coma - Authors' reply.

Lancet.
Edlow JA, Rabinstein A, Traub SJ, Wijdicks EF.
| Mar 28, 2015
178.

The future of WHO: outsourcing?

Lancet.
Dhillon RS.
| Mar 21, 2015
179.

5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.

Lancet.
Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG.
| Jun 20, 2015
180.

5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.

Lancet.
Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, Webb JG, Mack MJ, Douglas PS, Thourani VH, Babaliaros VC, Herrmann HC, Szeto WY, Pichard AD, Williams MR, Fontana GP, Miller DC, Anderson WN, Akin JJ, Davidson MJ, Smith CR.
| Jun 20, 2015